Luis Sobrevia | Medicine and Dentistry | Best Researcher Award

Prof. Luis Sobrevia | Medicine and Dentistry | Best Researcher Award

Prof. Luis Sobrevia, Pontificia Universidad Católica de Chile, Chile

Prof. Luis Sobrevia is a distinguished Chilean physiologist with extensive academic and research credentials. He completed his BSc in Biological Sciences from Universidad del Bío-Bío, MSc in Physiological Sciences from Universidad de Concepción, and PhD in Physiology and Biomedicine from King’s College London. He has held postdoctoral training at King’s College London and earned a Diploma in University Teaching from Pontificia Universidad Católica de Chile (PUC). As a Fellow of The Physiological Society (UK) and the International Union of Physiological Sciences, he holds prominent academic positions worldwide, including at PUC, TecSalud in Mexico, and UNESP in Brazil. His research focuses on placental vascular dysfunction in pregnancy complications like gestational diabetes and obesity, studying pathways that affect maternal-fetal health. He has mentored numerous PhD and MSc students and collaborates globally on groundbreaking research. 🌍🔬

Publication Profile

Education

Prof. Luis Sobrevia holds a BSc Hons. in Biological Sciences (1986) from Universidad del Bío-Bío, Chile, and an MSc in Physiology (1990) from Universidad de Concepción, Chile. He earned his PhD in Physiology and Biomedicine (1996) at King’s College London, UK, followed by a postdoctoral fellowship there. Prof. Sobrevia has held academic positions globally, currently serving as a Distinguished Research Professor at Tecnológico de Monterrey, Mexico, and as an Honorary Professor in Australia, Spain, and Brazil. His extensive experience spans physiology, biomedicine, and university teaching, making significant contributions to obstetrics and biomedical sciences. 🏥📚

 

Research

Prof. Luis Sobrevia leads an extensive research group comprising PhD students from various global institutions, such as PUC Chile, U Talca, UNESP Brazil, and U Coimbra, Portugal. His team includes MSc and undergraduate students, along with technical research assistants like biochemist K Silva. The group hosts postdoctoral researchers, including A Grismaldo and MA Pascon. Collaborations span prestigious institutions like University Medical Centre Groningen, TecSalud, and Karolinska Institutet. As a thesis supervisor, Prof. Sobrevia has mentored 69 students across PhD, MSc, and undergraduate levels, focusing on physiology, biomedicine, and molecular biology. 🌍📚💡

 

Teaching Experience 🎓📚

Prof. Luis Sobrevia is a dedicated educator, teaching undergraduate courses in Medicine, Biology, Biochemistry, Nutrition, and Bioethics. He also mentors postgraduate students, including PhD, MSc, and medical specialization programs. His teaching spans top universities in Chile (PUC, UCH, UT, UA, UACH, UDEC) and internationally at institutions like UMCG (Netherlands), US (Spain), KCL (UK), AUT (New Zealand), UQCCR (Australia), UNESP (Brazil), and TecMonterrey (Mexico). His expertise covers topics such as gestational diabetes, fetal vascular dysfunction, cardiovascular pathophysiology, endothelial physiology, and insulin and adenosine signaling. 🌍🩺📖

 

Academic and Scientific Merit Recognitions 🌟🏅

Prof. Luis Sobrevia has earned numerous prestigious awards and appointments throughout his academic career. In 2024, he was nominated as a Corresponding Member of the Chilean Academy of Sciences and recognized for his contributions to internationalization by the Mexican Society of Physiological Sciences. He was also appointed Co-president of the Regional Focal Point for Latin America and the Caribbean (RFP-LAC) of the International Science Council (ISC) and Editor-in-Chief of Physiological Minireviews. His leadership extends to roles such as Regional Editor for The Journal of Physiology and member of international scientific committees, highlighting his significant global impact. 🌍📚💡

 

Publication Top Notes

  • Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells by GE Mann, DL Yudilevich, L Sobrevia, Physiological reviews 83 (1), 183-252, Cited by: 578, 2003 📚💉
  • A gestational profile of placental exosomes in maternal plasma and their effects on endothelial cell migration by C Salomon, MJ Torres, M Kobayashi, K Scholz-Romero, L Sobrevia, PloS one 9 (6), e98667, Cited by: 412, 2014 🤰🔬
  • Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis by C Salomon, J Ryan, L Sobrevia, M Kobayashi, K Ashman, M Mitchell, PloS one 8 (7), e68451, Cited by: 400, 2013 🌱💧
  • Oxidative stress: Normal pregnancy versus preeclampsia by DI Chiarello, C Abad, D Rojas, F Toledo, CM Vázquez, A Mate, Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866 (2), 165354, Cited by: 325, 2020 🩸💔
  • Hypoxia-induced changes in the bioactivity of cytotrophoblast-derived exosomes by C Salomon, M Kobayashi, K Ashman, L Sobrevia, MD Mitchell, GE Rice, PloS one 8 (11), e79636, Cited by: 213, 2013 🌍💫
  • Dysfunction of the endothelial nitric oxide signalling pathway in diabetes and hyperglycaemia by L Sobrevia, GE Mann, Experimental Physiology: Translation and Integration 82 (3), 423-452, Cited by: 208, 1997 🧬🩺
  • Activation of L‐arginine transport (system y+) and nitric oxide synthase by elevated glucose and insulin in human endothelial cells by L Sobrevia, A Nadal, DL Yudilevich, GE Mann, The Journal of physiology 490 (3), 775-781, Cited by: 204, 1996 ⚡💡
  • Mice long-term high-fat diet feeding recapitulates human cardiovascular alterations: an animal model to study the early phases of diabetic cardiomyopathy by SD Calligaris, M Lecanda, F Solis, M Ezquer, J Gutierrez, E Brandan, PloS one 8 (4), e60931, Cited by: 189, 2013 🍔❤️
  • Extracellular vesicles in obesity and diabetes mellitus by F Pardo, R Villalobos-Labra, B Sobrevia, F Toledo, L Sobrevia, Molecular aspects of medicine 60, 81-91, Cited by: 187, 2018 🧬🍩
  • Early activation of the p42/p44MAPK pathway mediates adenosine‐induced nitric oxide production in human endothelial cells: a novel calcium‐insensitive … by AW Wyatt, JR Steinert, CPD Wheeler‐Jones, AJ Morgan, D Sugden, The FASEB journal 16 (12), 1584-1594, Cited by: 155, 2002 🔬💡

 

 

Dr. Miguel Virseda-Chamorro | Medicine | Best Paper Award

Dr. Miguel Virseda-Chamorro | Medicine | Best Paper Award 

Dr. Miguel Virseda-Chamorro, FEA, Hospital Nacional de parapléjicos, Spain.

Miguel Vírseda Chamorro is a seasoned medical professional with expertise in urology. Born in Zaragoza, Spain, in 1956, Miguel has dedicated over three decades to research, education, and clinical practice in the field of urology. Throughout his career, he has specialized in the treatment of lower urinary tract disorders, urological dysfunctions, and has made significant contributions through his research in the field of neurourology and urodynamics.

Profile

scopus

orcid

Strengths for the Award

  1. Extensive Research Background: Chamorro has participated in numerous clinical trials and published papers over decades, specifically focusing on urology and related areas such as spinal cord injuries and urinary tract infections.
  2. Recognized Expertise: His work has been acknowledged with multiple awards and recognitions, including best doctoral thesis and research prizes in the field of urology.
  3. International Contributions: Chamorro’s involvement in various international scientific meetings (e.g., International Continence Society) and peer-reviewed publications highlights his contributions to global scientific dialogue.
  4. Educational Contributions: Directing doctoral theses and contributing to advanced academic courses in urology positions him as a thought leader in his field.

Areas for Improvement

  • Interdisciplinary Reach: While his work is specialized in urology, expanding to interdisciplinary research that bridges other medical fields or innovations in treatment techniques might add depth to his paper’s impact.

Novel Research: Chamorro has done extensive work on known conditions, but for a “Best Paper Award,” research on cutting-edge topics, such as emerging technologies or new medical approaches, could further elevate his candidacy.

Education 🎓

Miguel Vírseda Chamorro has a diverse and accomplished educational background. He began his academic journey with a degree in Industrial Engineering at the Universidad Politécnica de Las Palmas in 1973. He later obtained his Licenciatura in Medicine and Surgery from the University of Valencia in 1981, followed by a degree in Law from the National University of Distance Education (UNED) in 2011. He specialized in Urology at Hospital Gómez Ulla in 1990 and pursued further studies, earning a Master’s in Design and Statistics in Health Sciences from the Autonomous University of Barcelona in 2001. His Doctoral Thesis, completed in 1992, received the prestigious Cum Laude distinction.

Experience 💼

Miguel’s career spans over three decades, including extensive experience in urological surgery, teaching, and research. He became a Fellow of the European Board of Urology in 1992 and has been an accredited Professor since 2005, working with several medical institutions. His medical experience is also enriched by his work as Director of Radiodiagnostic Installations, certified by the Spanish Nuclear Safety Council in 2007. He has served in various clinical roles, significantly contributing to both the practice and teaching of urology and urodynamics.

Research Interests 🔬

Miguel’s primary research interests lie in neurourology, urodynamics, and the impact of pelvic dysfunction on urinary systems. His research has focused on urinary tract dysfunctions, neurogenic detrusor overactivity, and the application of botulinum toxin in urological conditions. He is particularly interested in exploring diagnostic techniques, treatment methods, and prognostic factors for patients with spinal cord injuries and other neurological disorders affecting urological health.

Awards and Recognition 🏆

Miguel has been recognized with numerous awards for his outstanding work in the field of urology. In 1992, his doctoral thesis was awarded the Best Thesis Prize by the Spanish Association of Urology. He has received multiple accolades, including the Enrique Pérez Castro Third Prize for his research on urodynamic models in 1998, and the distinction for “Best Urological Functional Case” at the National Urology Congress in 2011. His latest recognition includes the ACACI Research Award for his study on chronic pelvic pain syndrome in women.

Publications 📚

Miguel has published extensively in renowned medical journals, contributing significantly to the field of urology. Below are some of his recent publications:

    1. Abdominal strength in voiding cystometry: a risk factor for recurrent urinary tract infections in women. Int Urogynecol J, 2015. Cited by: 45
    2. Risk factors of urethral diverticula in male patients with spinal cord injury. Spinal Cord, 2015. Cited by: 23
    3. Post Pelvic Radiotherapy Affectation of the Lower Urinary Tract Peripheral Innervation in Men. Urol Int, 2017. Cited by: 18
    4. Influence of bladder lithiasis on lower urinary tract dynamics in patients with spinal cord injury. Spinal Cord, 2017. Cited by: 30
    5. Clinical and urodynamic risk factors for recurrent urinary tract infections in multiple sclerosis. Multiple Sclerosis Journal, 2018. Cited by: 35

Conclusion

Chamorro’s achievements in urology and academic research, coupled with his global recognition, make him a strong contender for the award. Expanding his research focus and emphasizing innovation in his recent work would further bolster his potential for winning.

khadijeh kalanfarmanfarma | Health Professions Award | Best Researcher Award

Dr. khadijeh kalanfarmanfarma | Health Professions Award | Best Researcher Award

Dr. khadijeh kalanfarmanfarma, Kashan University of Medical Sciences, Kashan, Iran

Dr. Khadijeh Kalan Farmanfarma (born April 24, 1978) holds a PhD in Epidemiology and an M.Sc. in Health Education and Promotion. She has been recognized as a top researcher at both the national and university levels, notably at Zahedan University of Medical Sciences. Dr. Farmanfarma has contributed to over 20 high-impact publications, focusing on cancer epidemiology, metabolic syndrome, and public health. She is also a co-author of an eBook on the Renin-Angiotensin System and its role in diseases. Her research has earned her awards and recognition both nationally and internationally. 📚🌍🔬

 

Publication profile

Academic Background 🧠

Dr. Khadijeh Kalan Farmanfarma holds a PhD in Epidemiology and an M.Sc. in Health Education and Health Promotion. Her solid academic foundation is supported by multiple recognitions at the doctoral and master’s levels. Her focus on epidemiological research is crucial, particularly during global health challenges like COVID-19.

Research Contributions 📚

Dr. Farmanfarma has an impressive body of work, with more than 25 published research articles across Q1 to Q3 journals. Some highlights include:

COVID-19 Research: Her studies on the impact of COVID-19, especially on domestic violence and illness anxiety, show her commitment to addressing emerging public health issues.

Metabolic Syndrome & Cancer Epidemiology: Dr. Farmanfarma has published meta-analyses on metabolic syndrome and various cancers, which have gained significant attention in high-impact journals like Diabetes & Metabolic Syndrome: Clinical Research & Reviews (IF: 10.0, Q1).

Chronic Diseases & Breast Cancer Prevention: Her focus on chronic diseases and breast cancer prevention demonstrates her dedication to improving population health.

Recognitions 🏆

Dr. Farmanfarma’s accolades include being named the Top National Researcher and Top Researcher at Zahedan University of Medical Sciences multiple times, which speaks to her consistent excellence in research.

Publication Top Notes 

  • 📚 Prevalence of metabolic syndrome in Middle-East countries: Meta-analysis of cross-sectional studies – Cited by: 248 (2018)
  • 📚 Prevalence of metabolic syndrome in Iran: A meta-analysis of 69 studies – Cited by: 149 (2019)
  • 🧠 Brain cancer in the world: An epidemiological review – Cited by: 79 (2019)
  • 🎗️ Improving Breast Cancer Preventive Behavior among Female Medical Staff: Educational Intervention – Cited by: 59 (2014)
  • 📊 Epidemiologic study of gastric cancer in Iran: A systematic review – Cited by: 51 (2020)
  • 📈 Prevalence of type 2 diabetes in Middle-East: Systematic review & meta-analysis – Cited by: 47 (2020)
  • 🎗️ Effect of education on preventive behaviors of breast cancer in female teachers – Cited by: 35 (2014)
  • 🩺 Study of breast cancer knowledge, attitude, and preventive behaviors in Yazd, Iran – Cited by: 22 (2017)
  • 📊 Prevalence and trend of metabolic syndrome in South-East Iran – Cited by: 21 (2020)
  • 🧬 Testicular cancer in the world: An epidemiological review – Cited by: 20 (2018)

Conclusion 📝

With her extensive research output, recognitions, and focus on significant public health issues, Dr. Khadijeh Kalan Farmanfarma is a strong candidate for the Research for Best Researcher Award. Her diverse and impactful research contributions in epidemiology, particularly in chronic diseases and cancer, reflect a distinguished career deserving of recognition.

 

 

James Melrose | Health Professions | Best Researcher Award

Prof. James Melrose | Health Professions | Best Researcher Award

Prof. James Melrose, The University of Sydney, Australia

Based on the provided information, Prof. James Melrose appears to be a highly suitable candidate for the Research for Best Researcher Award. Here’s an evaluation of his qualifications:

Publication profile

Academic and Research Excellence

Prof. Melrose has a solid educational background with a B.Sc (Hons) in Biochemistry and a Ph.D. focused on carbohydrate metabolizing enzymes associated with barley. His long-standing affiliation with prestigious institutions such as The University of Sydney and the University of New South Wales highlights his strong academic and research credentials. Over a period of three decades, he has contributed significantly to bone and joint research, particularly in biochemical and immunological studies.

Special Awards and Recognitions

Prof. Melrose has received numerous prestigious awards throughout his career, demonstrating his recognition by the scientific community. Notable awards include the Smith and Nephew Award for his work on the spine, the Matrix Biology Society’s best poster award, and the European Spine Society’s GRAMMER Award. These accolades emphasize his contributions to the field of spine research and matrix biology, marking him as a leading researcher.

Teaching and Mentorship

Prof. Melrose has a strong background in teaching and mentorship, having served as a laboratory demonstrator, lecturer, and co-supervisor of Ph.D. students. His involvement in training and supervising research personnel at the Raymond Purves Bone and Joint Research Laboratories underscores his commitment to education and nurturing the next generation of researchers. This combination of research and teaching excellence enhances his candidacy for the award.

Publication Top Notes

  • 📚 “Are animal models useful for studying human disc disorders/degeneration?”
    • European Spine Journal 17, 2-19
    • Cited by: 854
    • Year: 2008
  • 📘 “Diverse cell signaling events modulated by perlecan”
    • Biochemistry 47 (43), 11174-11183
    • Cited by: 319
    • Year: 2008
  • 🔬 “Increased nerve and blood vessel ingrowth associated with proteoglycan depletion in an ovine anular lesion model of experimental disc degeneration”
    • Spine 27 (12), 1278-1285
    • Cited by: 255
    • Year: 2002
  • 🧬 “Proteoglycan degradation by the ADAMTS family of proteinases”
    • Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1812 (12)
    • Cited by: 249
    • Year: 2011
  • 🔍 “Keratan sulfate, a complex glycosaminoglycan with unique functional capability”
    • Glycobiology 28 (4), 182-206
    • Cited by: 226
    • Year: 2018
  • 🦴 “Proteoglycan 4 downregulation in a sheep meniscectomy model of early osteoarthritis”
    • Arthritis research & therapy 8, 1-6
    • Cited by: 200
    • Year: 2006
  • 💉 “Not all perlecans are created equal: interactions with fibroblast growth factor (FGF) 2 and FGF receptors”
    • Journal of Biological Chemistry 277 (17), 14657-14665
    • Cited by: 200
    • Year: 2002
  • 🔗 “A comparative analysis of the differential spatial and temporal distributions of the large (aggrecan, versican) and small (decorin, biglycan, fibromodulin) proteoglycans of the…”
    • The Journal of Anatomy 198 (1), 3-15
    • Cited by: 194
    • Year: 2001
  • 🧠 “Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms”
    • Journal of vascular surgery 24 (1), 82-92
    • Cited by: 173
    • Year: 1996
  • 📈 “Comparative spatial and temporal localisation of perlecan, aggrecan and type I, II and IV collagen in the ovine meniscus: an ageing study”
    • Histochemistry and cell biology 124, 225-235
    • Cited by: 164
    • Year: 2005

Conclusion

Prof. James Melrose’s extensive research experience, numerous awards, and significant contributions to biochemistry and spine research make him a highly deserving candidate for the Research for Best Researcher Award. His roles in teaching and mentoring further solidify his position as a leader in his field, making a lasting impact on both research and education.